Our analyses therefore suggests that TACR1 inhibition in neuroblastoma cells represses E2F2 and induces the pro-apoptotic TP53 pathway, indicating that E2F2 and TP53 may be downstream targets of TACR1 signaling. This evidence concerns the gene E2F2 and neuroblastoma.